Protein C and Apixaban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Protein C
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines affect how your blood clots, so using them together can raise your risk of bleeding. Apixaban (Eliquis) is a blood thinner that slows clotting. Protein C (Ceprotin) is a natural clotting-control protein that can also work against clot formation. Together, their effects can add up, and in some cases bleeding can become serious.
Please don't stop or change either medicine on your own. Your care team may watch you more closely and can adjust things as needed. Watch for warning signs like unusual bruising, pink or dark urine, black stools, nosebleeds that won't stop, or bleeding that won't quit. If any of these happen, get medical help right away.
Mechanism: Additive anticoagulation. Apixaban is a direct factor Xa inhibitor; protein C is an anticoagulant protein that inactivates factors Va and VIIIa. Combined use increases bleeding risk (neither is a prodrug; effect is direct and additive).
- Direction: Increased anticoagulant effect and bleeding risk.
- Magnitude: Pharmacodynamic; a 50-60% rise in anti-FXa activity was seen with apixaban plus enoxaparin as a comparator.
- Evidence: Probable. Severity: Major.
- Management: Assess bleeding risk; discontinue apixaban if active pathological bleeding occurs. Apixaban PD effect persists at least 24 hours. Reversal available; PCC, aPCC, or rFVIIa may be considered. During PCC use, PT/INR/aPTT and anti-FXa are not reliable.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
When apixaban, a factor Xa inhibitor, is given together with another anticoagulant, the likelihood of bleeding rises. Pharmacodynamic drug interaction studies of apixaban showed that combining apixaban with enoxaparin produced a 50% to 60% rise in anti-factor Xa activity. If active pathological bleeding develops, apixaban should be stopped. There is an available agent that reverses the anti-factor Xa activity of apixaban. Apixaban's pharmacodynamic effect is expected to remain for at least 24 hours following the final dose. Patients should be told about the signs and symptoms of blood loss and instructed to report them right away or present to an emergency room. Options that may be considered include prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa. If PCCs are administered, tracking apixaban's anticoagulation effect through a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity is not helpful and is not recommended. The absorption of apixaban is decreased by activated oral charcoal, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
The goal is to keep you safe while both medicines do their job. Keep taking both exactly as prescribed unless your care team tells you otherwise.
- Your team may monitor you more closely for bleeding and individualize your care.
- Learn the signs of blood loss: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, coughing or vomiting blood, or bleeding that won't stop.
- Report these immediately or go to an emergency room.
- If serious bleeding occurs, apixaban would be stopped; a reversal agent is available, and its effect can last at least 24 hours after the last dose.
Ask your pharmacist or prescriber any questions about balancing these two medicines.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations of pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was seen when apixaban and enoxaparin were given together 1.
Common questions
Can I take Protein C and Apixaban together?
Taking apixaban with protein C adds two anticoagulant effects together and raises the risk of serious bleeding, so keep both as prescribed, watch closely for bleeding signs, and get help right away if they appear. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Protein C and Apixaban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Protein C and Apixaban interaction managed?
The goal is to keep you safe while both medicines do their job. Keep taking both exactly as prescribed unless your care team tells you otherwise. Your team may monitor you more closely for bleeding and individualize your care. Learn the signs of blood loss: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, coughing or vomiting blood, or bleeding that won't stop. Report… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Protein C or Apixaban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Protein C
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist